Extremely low gestational age neonates (ELGANs), born before 28 weeks of gestation, face the greatest burden of neonatal mortality and morbidity, yet remain among the most underserved populations in clinical research. Most medications administered in the neonatal intensive care unit lack adequate safety, efficacy, and dosing data, and no major therapeutic advances have improved preterm survival since the introduction of surfactant in the early 1990s.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Danielle
Contact Danielle, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack